{"id":1074,"date":"2022-08-21T20:49:32","date_gmt":"2022-08-21T17:49:32","guid":{"rendered":"https:\/\/sites.uef.fi\/drug-targeting\/?page_id=1074"},"modified":"2026-07-03T15:41:05","modified_gmt":"2026-07-03T12:41:05","slug":"lat1","status":"publish","type":"page","link":"https:\/\/sites.uef.fi\/drug-targeting\/transporters\/lat1\/","title":{"rendered":"LAT1"},"content":{"rendered":"\n

L-Type Amino Acid Transporter 1 (LAT1)<\/strong> is a sodium- and pH-independent transporter responsible for the uptake of large neutral amino acids and several clinically used drugs, including L-DOPA, gabapentin, baclofen, and melphalan. LAT1 functions as a heterodimer consisting of a light chain (SLC7A5) and a heavy chain (CD98\/4F2hc; SLC3A2), which is required for proper localization and activity of the transporter.<\/p>\n\n\n\n

LAT1 is highly expressed in tissues with high amino acid demand, such as the brain and placenta, and is frequently upregulated in cancer cells and activated immune cells. Its expression at the blood\u2013brain barrier and in several disease-relevant tissues makes LAT1 an attractive target for transporter-mediated drug delivery and therapeutic intervention.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

LAT1 is one of the primary transporter platforms in our research.<\/strong> We investigate LAT1 as both a carrier and a therapeutic target, with applications ranging from brain- and cell-selective drug delivery to cancer-, pancreatic-, placental-, and mitochondrial-targeted therapies.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Selected Publications<\/h2>\n\n\n\n

Bahrami, K.; J\u00e4rvinen, J.; Laitinen, T.; Reinisalo, M.; Honkakoski, P.; Poso, A.; Huttunen, K. M.; Rautio, J. Structural features affecting selectivity of LAT1-targeted phenylalanine drug conjugates. Molecular Pharmaceutics<\/em><\/strong>, 2022<\/strong>, 20<\/em>(1):206-218. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00594<\/a><\/p>\n\n\n\n

Huttunen, J.; Agami, M.; Tampio, J.; Montaser, A. B.; Huttunen, K. M. Comparison of Experimental Strategies to Study L-Type Amino Acid Transporter 1 (LAT1) Utilization by Ligands. Molecules<\/em><\/strong>, 2021<\/strong>, 27<\/em>(1), 37, 37-57. https:\/\/doi.org\/10.3390\/molecules27010037<\/a><\/p>\n\n\n\n

Jalkanen, A.; Ihalainen, J.; Lehtonen, M.; Forsberg, M. M.; Rautio, J.; Huttunen, K. M.; Gynther, M. Species differences between mice and rats in the pharmacology of a LAT1-utilizing compound. International Journal of Pharmaceutics<\/strong><\/em>, 2021<\/strong>, 596<\/em>: 120300. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120300<\/a><\/p>\n\n\n\n

K\u00e4rkk\u00e4inen, J.; Laitinen, T.; Markowicz-Piasecka, M.; Montaser, A.; Lehtonen, M.; Rautio, J.; Gynther, M.; Poso, A.; Huttunen, K.M. Molecular characteristics supporting l-Type amino acid transporter 1 (LAT1)-mediated translocation. Bioorganic Chemistry<\/strong><\/em>, 2021<\/strong>, 112: 104921. https:\/\/doi.org\/10.1016\/j.bioorg.2021.104921<\/a><\/p>\n\n\n\n

Huttunen J.; Gynther, M.; Vellonen, K.-S.; Huttunen, K. M. L-Type Amino Acid Transporter 1 (LAT1)-Utilizing Prodrugs Are Carrier-Selective Despite Having Low Affinity for Organic Anion Transporting Polypeptides (OATPs). International Journal of Pharmaceutics<\/em><\/strong>, 2019<\/strong>, 571<\/em>, 11871410. http:\/\/doi.org\/10.1016\/j.ijpharm.2019.118714<\/a><\/p>\n\n\n\n

K\u00e4rkk\u00e4inen, J.; Gynther, M.; Kokkola, T.; Petsalo, A.; Auriola, S.; Lahtela-Kakkonen, M.; Laine, K.; Rautio, J.; Huttunen, K. M. Structural Properties for Selective and Efficient L-Type Amino Acid Transporter 1 (LAT1)- Mediated Cellular Uptake. International Journal of Pharmaceutics<\/em><\/strong>, 2018<\/strong>, 544<\/em> (1), 91-99. http:\/\/doi.org\/10.1016\/j.ijpharm.2018.04.025<\/a><\/p>\n\n\n\n

Huttunen, K. M.; Huttunen, J.; Aufderhaar, I.; Gynther, M.; Denny, W. A.; Spicer, J. A. L-Type Amino Acid Transporter 1 (LAT1)- Mediated Targeted Delivery of Perforin Inhibitors. International Journal of Pharmaceutics<\/em><\/strong>, 2015<\/strong>, 498<\/em> (1-2), 205-216. http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2015.12.034<\/a><\/p>\n\n\n\n

Ylikangas, H.; Malmioja, K.; Peura, L.; Gynther, M.; Nwachukwu, E. O.; Lepp\u00e4nen, J.; Laine, K.; Rautio, J.; Lahtela-Kakkonen, M.; Huttunen, K. M.; Poso, A. Quantitative Insights for the Design of Compounds Recognized by L-Type Amino Acid Transporter 1 (LAT1). ChemMedChem<\/em><\/strong>, 2014<\/strong>, 9<\/em> (12), 2699-2707. http:\/\/dx.doi.org\/10.1002\/cmdc.201402281<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

L-Type Amino Acid Transporter 1 (LAT1) is a sodium- and pH-independent transporter responsible for the uptake of large neutral amino acids and several clinically used drugs, including L-DOPA, gabapentin, baclofen, and melphalan. LAT1 functions as a heterodimer consisting of a light chain (SLC7A5) and a heavy chain (CD98\/4F2hc; SLC3A2), which is required for proper localization […]<\/p>\n","protected":false},"author":140,"featured_media":0,"parent":1047,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-1074","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nLAT1 - Transporter Targeted Drug Delivery<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sites.uef.fi\/drug-targeting\/transporters\/lat1\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LAT1 - Transporter Targeted Drug Delivery\" \/>\n<meta property=\"og:description\" content=\"L-Type Amino Acid Transporter 1 (LAT1) is a sodium- and pH-independent transporter responsible for the uptake of large neutral amino acids and several clinically used drugs, including L-DOPA, gabapentin, baclofen, and melphalan. LAT1 functions as a heterodimer consisting of a light chain (SLC7A5) and a heavy chain (CD98\/4F2hc; SLC3A2), which is required for proper localization […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sites.uef.fi\/drug-targeting\/transporters\/lat1\/\" \/>\n<meta property=\"og:site_name\" content=\"Transporter Targeted Drug Delivery\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-03T12:41:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sites.uef.fi\/drug-targeting\/wp-content\/uploads\/sites\/59\/2022\/12\/Graphical-Abstract-1024x566.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"566\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/sites.uef.fi\\\/drug-targeting\\\/transporters\\\/lat1\\\/\",\"url\":\"https:\\\/\\\/sites.uef.fi\\\/drug-targeting\\\/transporters\\\/lat1\\\/\",\"name\":\"LAT1 - Transporter Targeted Drug Delivery\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sites.uef.fi\\\/drug-targeting\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/sites.uef.fi\\\/drug-targeting\\\/transporters\\\/lat1\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/sites.uef.fi\\\/drug-targeting\\\/transporters\\\/lat1\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sites.uef.fi\\\/drug-targeting\\\/wp-content\\\/uploads\\\/sites\\\/59\\\/2022\\\/12\\\/Graphical-Abstract-1024x566.png\",\"datePublished\":\"2022-08-21T17:49:32+00:00\",\"dateModified\":\"2026-07-03T12:41:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/sites.uef.fi\\\/drug-targeting\\\/transporters\\\/lat1\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/sites.uef.fi\\\/drug-targeting\\\/transporters\\\/lat1\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/sites.uef.fi\\\/drug-targeting\\\/transporters\\\/lat1\\\/#primaryimage\",\"url\":\"https:\\\/\\\/sites.uef.fi\\\/drug-targeting\\\/wp-content\\\/uploads\\\/sites\\\/59\\\/2022\\\/12\\\/Graphical-Abstract.png\",\"contentUrl\":\"https:\\\/\\\/sites.uef.fi\\\/drug-targeting\\\/wp-content\\\/uploads\\\/sites\\\/59\\\/2022\\\/12\\\/Graphical-Abstract.png\",\"width\":4353,\"height\":2407},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/sites.uef.fi\\\/drug-targeting\\\/transporters\\\/lat1\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/sites.uef.fi\\\/drug-targeting\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Transporters We Study\",\"item\":\"https:\\\/\\\/sites.uef.fi\\\/drug-targeting\\\/transporters\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"LAT1\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/sites.uef.fi\\\/drug-targeting\\\/#website\",\"url\":\"https:\\\/\\\/sites.uef.fi\\\/drug-targeting\\\/\",\"name\":\"Transporter Targeted Drug Delivery\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/sites.uef.fi\\\/drug-targeting\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LAT1 - Transporter Targeted Drug Delivery","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sites.uef.fi\/drug-targeting\/transporters\/lat1\/","og_locale":"en_US","og_type":"article","og_title":"LAT1 - Transporter Targeted Drug Delivery","og_description":"L-Type Amino Acid Transporter 1 (LAT1) is a sodium- and pH-independent transporter responsible for the uptake of large neutral amino acids and several clinically used drugs, including L-DOPA, gabapentin, baclofen, and melphalan. LAT1 functions as a heterodimer consisting of a light chain (SLC7A5) and a heavy chain (CD98\/4F2hc; SLC3A2), which is required for proper localization […]","og_url":"https:\/\/sites.uef.fi\/drug-targeting\/transporters\/lat1\/","og_site_name":"Transporter Targeted Drug Delivery","article_modified_time":"2026-07-03T12:41:05+00:00","og_image":[{"width":1024,"height":566,"url":"https:\/\/sites.uef.fi\/drug-targeting\/wp-content\/uploads\/sites\/59\/2022\/12\/Graphical-Abstract-1024x566.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/sites.uef.fi\/drug-targeting\/transporters\/lat1\/","url":"https:\/\/sites.uef.fi\/drug-targeting\/transporters\/lat1\/","name":"LAT1 - Transporter Targeted Drug Delivery","isPartOf":{"@id":"https:\/\/sites.uef.fi\/drug-targeting\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sites.uef.fi\/drug-targeting\/transporters\/lat1\/#primaryimage"},"image":{"@id":"https:\/\/sites.uef.fi\/drug-targeting\/transporters\/lat1\/#primaryimage"},"thumbnailUrl":"https:\/\/sites.uef.fi\/drug-targeting\/wp-content\/uploads\/sites\/59\/2022\/12\/Graphical-Abstract-1024x566.png","datePublished":"2022-08-21T17:49:32+00:00","dateModified":"2026-07-03T12:41:05+00:00","breadcrumb":{"@id":"https:\/\/sites.uef.fi\/drug-targeting\/transporters\/lat1\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sites.uef.fi\/drug-targeting\/transporters\/lat1\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sites.uef.fi\/drug-targeting\/transporters\/lat1\/#primaryimage","url":"https:\/\/sites.uef.fi\/drug-targeting\/wp-content\/uploads\/sites\/59\/2022\/12\/Graphical-Abstract.png","contentUrl":"https:\/\/sites.uef.fi\/drug-targeting\/wp-content\/uploads\/sites\/59\/2022\/12\/Graphical-Abstract.png","width":4353,"height":2407},{"@type":"BreadcrumbList","@id":"https:\/\/sites.uef.fi\/drug-targeting\/transporters\/lat1\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sites.uef.fi\/drug-targeting\/"},{"@type":"ListItem","position":2,"name":"Transporters We Study","item":"https:\/\/sites.uef.fi\/drug-targeting\/transporters\/"},{"@type":"ListItem","position":3,"name":"LAT1"}]},{"@type":"WebSite","@id":"https:\/\/sites.uef.fi\/drug-targeting\/#website","url":"https:\/\/sites.uef.fi\/drug-targeting\/","name":"Transporter Targeted Drug Delivery","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sites.uef.fi\/drug-targeting\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/sites.uef.fi\/drug-targeting\/wp-json\/wp\/v2\/pages\/1074","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sites.uef.fi\/drug-targeting\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.uef.fi\/drug-targeting\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.uef.fi\/drug-targeting\/wp-json\/wp\/v2\/users\/140"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.uef.fi\/drug-targeting\/wp-json\/wp\/v2\/comments?post=1074"}],"version-history":[{"count":1,"href":"https:\/\/sites.uef.fi\/drug-targeting\/wp-json\/wp\/v2\/pages\/1074\/revisions"}],"predecessor-version":[{"id":2395,"href":"https:\/\/sites.uef.fi\/drug-targeting\/wp-json\/wp\/v2\/pages\/1074\/revisions\/2395"}],"up":[{"embeddable":true,"href":"https:\/\/sites.uef.fi\/drug-targeting\/wp-json\/wp\/v2\/pages\/1047"}],"wp:attachment":[{"href":"https:\/\/sites.uef.fi\/drug-targeting\/wp-json\/wp\/v2\/media?parent=1074"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}